News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
96,622 Results
Type
Article (3134)
Company Profile (22)
Press Release (93466)
Section
Business (38768)
Career Advice (65)
Deals (5971)
Drug Delivery (12)
Drug Development (11592)
Employer Resources (8)
FDA (2098)
Job Trends (2400)
News (56200)
Policy (3427)
Tag
Academia (278)
Accelerated approval (11)
Adcomms (2)
Allergies (40)
Alliances (3563)
ALS (21)
Alzheimer's disease (252)
Antibody-drug conjugate (ADC) (73)
Approvals (2275)
Artificial intelligence (57)
Autoimmune disease (42)
Automation (4)
Bankruptcy (17)
Best Places to Work (2202)
Biosimilars (25)
Biotechnology (17)
Bladder cancer (47)
Brain cancer (10)
Breast cancer (189)
Cancer (1166)
Cardiovascular disease (70)
Career advice (63)
Career pathing (4)
CAR-T (42)
CDC (3)
Celiac Disease (1)
Cell therapy (110)
Cervical cancer (7)
Clinical research (11344)
Collaboration (231)
Compensation (300)
Complete response letters (10)
COVID-19 (241)
CRISPR (19)
C-suite (144)
Cystic fibrosis (31)
Data (1673)
Depression (40)
Diabetes (84)
Diagnostics (923)
Digital health (12)
Diversity, equity & inclusion (1)
Drug discovery (43)
Drug pricing (11)
Drug shortages (3)
Duchenne muscular dystrophy (53)
Earnings (34684)
Editorial (10)
Employer branding (2)
Employer resources (7)
Events (12195)
Executive appointments (69)
FDA (2966)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (5)
Frontotemporal dementia (9)
Funding (167)
Gene editing (34)
Generative AI (6)
Gene therapy (89)
GLP-1 (158)
Government (455)
Grass and pollen (1)
Guidances (295)
Healthcare (2851)
HIV (13)
Huntington's disease (7)
IgA nephropathy (24)
Immunology and inflammation (44)
Immuno-oncology (15)
Indications (48)
Infectious disease (292)
Inflammatory bowel disease (32)
Inflation Reduction Act (1)
Influenza (18)
Intellectual property (49)
Interviews (9)
IPO (4273)
IRA (3)
Job creations (299)
Job search strategy (53)
JPM (2)
Kidney cancer (6)
Labor market (22)
Layoffs (70)
Leadership (2)
Legal (575)
Liver cancer (14)
Longevity (1)
Lung cancer (162)
Lymphoma (161)
Machine learning (2)
Management (2)
Manufacturing (93)
MASH (33)
Medical device (2203)
Medtech (2222)
Mergers & acquisitions (1891)
Metabolic disorders (209)
Multiple sclerosis (44)
NASH (3)
Neurodegenerative disease (47)
Neuropsychiatric disorders (17)
Neuroscience (494)
NextGen: Class of 2026 (800)
Non-profit (391)
Now hiring (5)
Obesity (87)
Opinion (7)
Ovarian cancer (40)
Pain (38)
Pancreatic cancer (55)
Parkinson's disease (60)
Partnered (1)
Patents (72)
Patient recruitment (114)
Peanut (13)
People (3325)
Pharmaceutical (7)
Pharmacy benefit managers (5)
Phase 1 (2744)
Phase 2 (4617)
Phase 3 (4784)
Pipeline (2600)
Policy (4)
Postmarket research (441)
Preclinical (760)
Press Release (1)
Prostate cancer (51)
Psychedelics (4)
Radiopharmaceuticals (55)
Rare diseases (167)
Real estate (388)
Recruiting (3)
Regulatory (3236)
Reports (15)
Research institute (221)
Resumes & cover letters (4)
Rett syndrome (6)
RNA editing (3)
RSV (23)
Schizophrenia (27)
Series A (28)
Series B (25)
Service/supplier (2)
Sickle cell disease (19)
Special edition (8)
Spinal muscular atrophy (53)
Sponsored (2)
Startups (264)
Stomach cancer (3)
Supply chain (8)
Tariffs (2)
The Weekly (4)
Vaccines (111)
Venture capital (13)
Weight loss (44)
Women's health (16)
Worklife (5)
Date
Today (82)
Last 7 days (332)
Last 30 days (1193)
Last 365 days (7723)
2026 (1944)
2025 (6385)
2024 (6125)
2023 (6916)
2022 (8318)
2021 (8139)
2020 (8155)
2019 (6925)
2018 (5075)
2017 (4621)
2016 (3831)
2015 (4367)
2014 (3197)
2013 (2087)
2012 (2497)
2011 (2731)
2010 (2789)
Location
Africa (75)
Alabama (40)
Alaska (1)
Arizona (46)
Asia (5511)
Australia (965)
California (2421)
Canada (615)
China (182)
Colorado (104)
Connecticut (90)
Delaware (105)
Europe (15353)
Florida (390)
Georgia (81)
Hawaii (1)
Idaho (8)
Illinois (148)
India (9)
Indiana (133)
Iowa (6)
Japan (142)
Kansas (17)
Kentucky (8)
Louisiana (9)
Maine (22)
Maryland (242)
Massachusetts (1851)
Michigan (52)
Minnesota (139)
Missouri (19)
Montana (3)
Nebraska (2)
Nevada (19)
New Hampshire (16)
New Jersey (734)
New York (648)
North Carolina (290)
North Dakota (1)
Northern California (1341)
Ohio (53)
Oklahoma (1)
Oregon (3)
Pennsylvania (493)
Puerto Rico (1)
South America (115)
South Carolina (9)
Southern California (940)
Tennessee (29)
Texas (379)
United States (8689)
Utah (59)
Virginia (25)
Washington D.C. (3)
Washington State (226)
Wisconsin (14)
96,622 Results for "32".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Kainova Therapeutics Secures $32M CAD to Accelerate Development of Immuno-Oncology and Inflammation Therapies
February 10, 2026
·
4 min read
Press Releases
Colorado’s Life Sciences Ecosystem Raised $3.2 Billion in 2025
January 12, 2026
·
1 min read
Press Releases
Arch Biopartners Scientists Publish New Data Linking the Cytokine IL-32 to Inflammation and Diabetic Kidney Disease
February 9, 2026
·
5 min read
Press Releases
32 Biosciences to Launch $40 Million Series A at J.P. Morgan to Advance First-in-Class GI Mucosal-Immune Therapeutics
January 8, 2026
·
4 min read
Press Releases
Avanzanite Bioscience Secures €32M Series A Investment from MVM Partners
November 18, 2025
·
3 min read
Press Releases
LEO Pharma Announces Positive Topline 32-Week Key Results in ADHAND Trial
November 17, 2025
·
8 min read
Press Releases
Empty Capsules Market Size to Hit $5.32 Billion by 2032, Coherent Market Insights
November 3, 2025
·
1 min read
Press Releases
Radiation Oncology Market Size to Surpass USD 32.82 Billion by 2034
October 8, 2025
·
1 min read
Press Releases
Feinstein Institutes Awarded $3.2M Grant to Advance Polygenic Embryo Selection Research
October 23, 2025
·
3 min read
Mergers & acquisitions
Merck Backs Off Revolution After Failing To Agree on Price: WSJ
Merck had previously offered anywhere from $28 billion to $32 billion to swallow Revolution Medicines.
January 26, 2026
·
1 min read
·
Tristan Manalac
1 of 9,663
Next
